BMI View: Ghana remains an attractive investment prospect for foreign drugmakers operating in Sub-
Saharan Africa, and stabilising the national health insurance scheme provides an upside risk to our outlook
for the pharmaceutical sector. The Ghanaian government is act ..."
BMI View: The Ghanaian government will retain its support towards domestic pharmaceutical
manufacturers in the country, in hope of achieving status as the Economic Communities of West African
States' hub for pharmaceutical and healthcare investment. Larger domestic ma ..."
BMI View: The Ghanaian government is actively making progress towards fulfilling its ambition of being
the Economic Communities of West African States (ECOWAS) hub for pharmaceutical and healthcare
investment. Domestic drugmakers are in a favourable position to take a ..."
BMI View: Should Ghana's government allocate the funds required for local producer Danadams to gain
WHO certification, the company will boost its presence both domestically and internationally. This would
allow Ghana to reduce its unsustainable reliance on imported ph ..."
BMI View: Ghana's pharmaceutical and healthcare sectors will continue to garner much interest from
international investors given the huge market growth potential. In the short term, however, risks relating to
healthcare funding, insurance expansion and economic growth ..."
BMI View: Our growth outlook for Ghana's pharmaceutical expenditure is positive, and will be driven by
expanding NHIS coverage and improving public healthcare provision. Further reforms to Ghana's National
Health Insurance Scheme (NHIS) will allow the scheme's continu ..."
BMI View: Our outlook for Ghana's pharmaceutical and healthcare market is becoming increasingly
bearish. The National Health Insurance Scheme is facing backlash from both drugmakers and service
providers due to a lack of payments. Furthermore, we believe that the sche ..."
BMI View: We anticipate that the continuing roll-out of biometric registration and expansion of the
community-based health planning and services scheme will lead to greater uptake of the National Health
Insurance scheme (NHIS) and hence increasing demand for pharmaceu ..."
Ghana Pharmaceuticals & Healthcare Report
We remain of the view that Ghana will be a regional outperformer in terms of the development of its pharmaceutical and healthcare markets over the medium to longer term . On the other hand, reliance on donations and foreign aid to ..."
BMI View: Continuing depreciation in the Ghanaian currency has led us to revise our headline forecasts in
USD for the pharmaceutical sector downwards. In the long-term however we remain positive for the sector
with the government's focus on domestic pharmaceutical sector, great ..."